Ident. | Authors (with country if any) | Title |
---|
000007 (2020) |
Y. Shi [République populaire de Chine] ; N. Wang [République populaire de Chine] ; Q M Zou [République populaire de Chine] | [Progress and challenge of vaccine development against 2019 novel coronavirus (2019-nCoV)]. |
000008 (2020) |
H. Li [République populaire de Chine] ; Y M Wang [République populaire de Chine] ; J Y Xu [République populaire de Chine] ; B. Cao [République populaire de Chine] | [Potential antiviral therapeutics for 2019 Novel Coronavirus]. |
000022 (2020) |
Catrin Sohrabi [Royaume-Uni] ; Zaid Alsafi [Royaume-Uni] ; Niamh O'Neill [Royaume-Uni] ; Mehdi Khan [Royaume-Uni] ; Ahmed Kerwan [Royaume-Uni] ; Ahmed Al-Jabir [Royaume-Uni] ; Christos Iosifidis [Royaume-Uni] ; Riaz Agha [Royaume-Uni] | World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19) |
000030 (2020) |
Yixuan Wang [République populaire de Chine] ; Yuyi Wang [République populaire de Chine] ; Yan Chen [République populaire de Chine] ; Qingsong Qin [République populaire de Chine] | Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. |
000036 (2020) |
Mary E. Wilson [États-Unis] ; Lin H. Chen [États-Unis] | Travellers give wings to novel coronavirus (2019-nCoV). |
000045 (2020) |
Carlo Contini [Italie] ; Mariachiara Di Nuzzo [Italie] ; Nicole Barp [Italie] ; Aurora Bonazza [Italie] ; Roberto De Giorgio [Italie] ; Mauro Tognon [Italie] ; Salvatore Rubino [Italie] | The novel zoonotic COVID-19 pandemic: An expected global health concern. |
000049 (2020) |
Suliman Khan [République populaire de Chine] ; Rabeea Siddique [République populaire de Chine] ; Muhammad Adnan Shereen [République populaire de Chine] ; Ashaq Ali [République populaire de Chine] ; Jianbo Liu ; Qian Bai [République populaire de Chine] ; Nadia Bashir [République populaire de Chine] ; Mengzhou Xue [République populaire de Chine] | The emergence of a novel coronavirus (SARS-CoV-2), their biology and therapeutic options. |
000050 (2020) |
Yongshi Yang [République populaire de Chine] ; Fujun Peng [République populaire de Chine] ; Runsheng Wang [République populaire de Chine] ; Kai Guan [République populaire de Chine] ; Taijiao Jiang [République populaire de Chine] ; Guogang Xu [République populaire de Chine] ; Jinlyu Sun [République populaire de Chine] ; Christopher Chang [États-Unis] | The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China |
000055 (2020) |
Noah C. Peeri [États-Unis] ; Nistha Shrestha [États-Unis] ; Md Siddikur Rahman [Bangladesh] ; Rafdzah Zaki [Malaisie] ; Zhengqi Tan [États-Unis] ; Saana Bibi [Pakistan] ; Mahdi Baghbanzadeh [Iran] ; Nasrin Aghamohammadi [Malaisie] ; Wenyi Zhang [République populaire de Chine] ; Ubydul Haque [États-Unis] | The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? |
000058 (2020) |
Sarju Ganatra [États-Unis] ; Sarah P. Hammond [États-Unis] ; Anju Nohria [États-Unis] | The Novel Coronavirus Disease (COVID-19) Threat for Patients with Cardiovascular Disease and Cancer. |
000060 (2020) |
Yuxin Yan [République populaire de Chine] ; Woo In Shin [Malaisie] ; Yoong Xin Pang [République populaire de Chine] ; Yang Meng [République populaire de Chine] ; Jianchen Lai [République populaire de Chine] ; Chong You [République populaire de Chine] ; Haitao Zhao [États-Unis] ; Edward Lester [Royaume-Uni] ; Tao Wu [République populaire de Chine] ; Cheng Heng Pang [République populaire de Chine] | The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment. |
000063 (2020) |
Pranab Chatterjee [Inde] ; Nazia Nagi [Inde] ; Anup Agarwal [Inde] ; Bhabatosh Das [Inde] ; Sayantan Banerjee [Inde] ; Swarup Sarkar [Inde] ; Nivedita Gupta [Inde] ; Raman R. Gangakhedkar [Inde] | The 2019 novel coronavirus disease (COVID-19) pandemic: A review of the current evidence. |
000066 (2020) |
Naidi Yang [République populaire de Chine] ; Han-Ming Shen [République populaire de Chine] | Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19 |
000089 (2020) |
D. Katterine Bonilla-Aldana | SARS-CoV, MERS-CoV and now the 2019-novel CoV: Have we investigated enough about coronaviruses? – A bibliometric analysis☆ |
000097 (2020) |
Shuntong Kang [République populaire de Chine] ; Wenyao Peng [République populaire de Chine] ; Yuhao Zhu [République populaire de Chine] ; Shiyao Lu [République populaire de Chine] ; Min Zhou [République populaire de Chine] ; Wei Lin [République populaire de Chine] ; Wenfang Wu [République populaire de Chine] ; Shu Huang [République populaire de Chine] ; Liping Jiang [République populaire de Chine] ; Xuan Luo [République populaire de Chine] ; Meichun Deng [République populaire de Chine] | Recent progress in understanding 2019 novel coronavirus (SARS-CoV-2) associated with human respiratory disease: detection, mechanisms and treatment |
000104 (2020) |
James Segars [États-Unis] ; Quinton Katler [Géorgie (pays)] ; Dana B. Mcqueen [États-Unis] ; Alexander Kotlyar [États-Unis] ; Tanya Glenn [États-Unis] ; Zac Knight [États-Unis] ; Eve C. Feinberg [États-Unis] ; Hugh S. Taylor [États-Unis] ; James P. Toner [Géorgie (pays)] ; Jennifer F. Kawwass [Géorgie (pays)] | Prior and Novel Coronaviruses, COVID-19, and Human Reproduction: What Is Known? |
000105 (2020) |
Sai Krishna Gudi [Canada] ; Komal Krishna Tiwari [Canada] | Preparedness and Lessons Learned from the Novel Coronavirus Disease. |
000106 (2020) |
Shi Zhao [République populaire de Chine] ; Qianyin Lin [États-Unis] ; Jinjun Ran [République populaire de Chine] ; Salihu S. Musa [République populaire de Chine] ; Guangpu Yang [République populaire de Chine] ; Weiming Wang [République populaire de Chine] ; Yijun Lou [République populaire de Chine] ; Daozhou Gao [République populaire de Chine] ; Lin Yang [République populaire de Chine] ; Daihai He [République populaire de Chine] ; Maggie H. Wang [République populaire de Chine] | Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak |
000109 (2020) |
Lei Zhang [République populaire de Chine] ; Yunhui Liu [République populaire de Chine] | Potential interventions for novel coronavirus in China: A systematic review. |
000110 (2020) |
Junxiong Pang [Singapour] ; Min Xian Wang [Singapour] ; Ian Yi Han Ang ; Sharon Hui Xuan Tan ; Ruth Frances Lewis ; Jacinta I-Pei Chen ; Ramona A. Gutierrez ; Sylvia Xiao Wei Gwee [Singapour] ; Pearleen Ee Yong Chua [Singapour] ; Qian Yang ; Xian Yi Ng ; Rowena K. S. Yap ; Hao Yi Tan ; Yik Ying Teo ; Chorh Chuan Tan ; Alex R. Cook ; Jason Chin-Huat Yap ; Li Yang Hsu | Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review |
000129 (2020) |
Zachary J. Sandler [États-Unis] ; Mason R. Firpo [États-Unis] ; Oreoluwa S. Omoba [États-Unis] ; Michelle N. Vu [États-Unis] ; Vineet D. Menachery [États-Unis] ; Bryan C. Mounce [États-Unis] | Novel ionophores active against La Crosse virus identified through rapid antiviral screening. |